{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:46:47Z","timestamp":1792525607018,"version":"4.5.0"},"reference-count":204,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jaip.2023.04.018","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:53:05Z","timestamp":1682650385000},"page":"1602-1622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Inborn Errors of Immunity and Autoimmune Disease"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2057-3968","authenticated-orcid":false,"given":"Paul Edgar","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementine","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.04.018_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.anai.2019.07.014","article-title":"Autoimmunity in common variable immunodeficiency","volume":"123","author":"Agarwal","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib3","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3389\/fimmu.2018.01535","article-title":"A\u00a0mutation outside the dimerization domain causing atypical STING-associated vasculopathy with onset in infancy","volume":"9","author":"Saldanha","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/rheumatology\/key419","article-title":"A\u00a0case of systemic lupus erythematosus with C1q deficiency, increased serum interferon-\u03b1 levels and high serum interferogenic activity","volume":"58","author":"Bolin","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2023.04.018_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","article-title":"The world incidence and prevalence of autoimmune diseases is increasing","volume":"3","author":"Lerner","year":"2016","journal-title":"Int J Celiac Dis"},{"key":"10.1016\/j.jaip.2023.04.018_bib6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.04.018_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.diabres.2013.11.005","article-title":"Diabetes in the young \u2013 a global view and worldwide estimates of numbers of children with type 1 diabetes","volume":"103","author":"Patterson","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jaip.2023.04.018_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Chapter 1: epidemiology of type 1 diabetes","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jaip.2023.04.018_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1464-5491.2006.01925.x","article-title":"Incidence and trends of childhood type 1 diabetes worldwide 1990\u20131999","volume":"23","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib10","article-title":"A\u00a0potential link between environmental triggers and autoimmunity","volume":"2014","author":"Vojdani","year":"2014","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jaip.2023.04.018_bib11","first-page":"285","article-title":"Rare autoimmune disorders with Mendelian inheritance","volume":"49","author":"Plander","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2023.04.018_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002293","article-title":"A\u00a0genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci","volume":"7","author":"Bradfield","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0092-8674(00)81110-1","article-title":"Genetic analysis of autoimmune disease","volume":"85","author":"Vyse","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2023.04.018_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jaut.2009.07.008","article-title":"The genetics of human autoimmune disease","volume":"33","author":"Invernizzi","year":"2009","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2023.04.018_bib16","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0362","article-title":"Expression quantitative trait loci: present and future","volume":"368","author":"Nica","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.jaip.2023.04.018_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2015.09.001","article-title":"Identifying genetic determinants of autoimmunity and immune dysregulation","volume":"37","author":"Lucas","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fped.2019.00461","article-title":"Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders","volume":"7","author":"Bakhtiar","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2023.04.018_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib21","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3389\/fimmu.2017.01965","article-title":"Clinical implications of digenic inheritance and epistasis in primary immunodeficiency disorders","volume":"8","author":"Ameratunga","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaci.2015.06.048","article-title":"Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry","volume":"137","author":"Cetica","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2011.01.039","article-title":"Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants","volume":"127","author":"Osborne","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2014.07.033","article-title":"Filaggrin loss-of-function mutations are associated with food allergy in childhood and adolescence","volume":"134","author":"Venkataraman","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib25","first-page":"200","article-title":"Mutations in the filaggrin gene and food allergy","volume":"9","author":"Ogrodowczyk","year":"2014","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.jaip.2023.04.018_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.163.3.286","article-title":"Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study","volume":"163","author":"Fasano","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.genom.4.070802.110432","article-title":"The genetics of narcolepsy","volume":"4","author":"Chabas","year":"2003","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2023.04.018_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2014-05-573105","article-title":"Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis","volume":"124","author":"Zhang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fendo.2016.00021","article-title":"Dissecting the genetic susceptibility to Graves\u2019 disease in a cohort of patients of Italian origin","volume":"7","author":"Lombardi","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaip.2023.04.018_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ACI.0000000000000689","article-title":"Primary immune regulatory disorders: a growing universe of immune dysregulation","volume":"20","author":"Chan","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib33","first-page":"1","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"24","author":"Tangye","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2023.04.018_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10875-014-9987-5","article-title":"Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients","volume":"34","author":"Sarkadi","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib37","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0706487","article-title":"Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen","volume":"358","author":"Alimohammadi","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib38","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nri2450","article-title":"Transcriptional regulation by AIRE: molecular mechanisms of central tolerance","volume":"8","author":"Peterson","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib39","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3389\/fimmu.2017.01066","article-title":"Novel mutations of the tetratricopeptide repeat domain 7A gene and phenotype\/genotype comparison","volume":"8","author":"Lien","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1530\/EJE-10-1206","article-title":"Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome","volume":"165","author":"Lima","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jaip.2023.04.018_bib41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/pai.12420","article-title":"Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients","volume":"26","author":"Di Cesare","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib42","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jaci.2011.06.043","article-title":"Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome","volume":"128","author":"Tison","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2007.01949.x","article-title":"Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome","volume":"66","author":"McLean-Tooke","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-016-0606-9","article-title":"T\u00a0regulatory cell biology in health and disease","volume":"16","author":"Alroqi","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2023.04.018_bib45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","article-title":"An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy","volume":"100","author":"Powell","year":"1982","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2023.04.018_bib46","first-page":"461","article-title":"X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3","volume":"66","author":"Bennett","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jaci.2019.03.003","article-title":"The FOXP3\u03942 isoform supports Treg cell development and protects against severe IPEX syndrome","volume":"144","author":"Frith","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","article-title":"CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked\u2013like syndrome, and defective IL-10 expression from CD4 lymphocytes","volume":"119","author":"Caudy","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib52","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib53","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib54","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/TACG.S213920","article-title":"Autoimmunity in Wiskott\u2013Aldrich syndrome: updated perspectives","volume":"14","author":"Sudhakar","year":"2021","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.20061338","article-title":"The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells","volume":"204","author":"Maillard","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaci.2014.10.019","article-title":"Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA","volume":"135","author":"Charbonnier","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib58","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","article-title":"Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation","volume":"131","author":"Engelhardt","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib59","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41467-019-14112-2","article-title":"Attenuation of TCR-induced transcription by Bach2 controls regulatory T cell differentiation and homeostasis","volume":"11","author":"Sidwell","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2023.04.018_bib60","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2019.11.043","article-title":"Treatment with rapamycin can restore regulatory T-cell function in IPEX patients","volume":"145","author":"Passerini","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib61","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2009.07991.x","article-title":"Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)","volume":"148","author":"Teachey","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2023.04.018_bib63","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaci.2016.11.033","article-title":"Autoimmune lymphoproliferative syndrome caused by homozygous FAS mutations with normal or residual protein expression","volume":"140","author":"Agrebi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib64","first-page":"1347","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science (1979)"},{"key":"10.1016\/j.jaip.2023.04.018_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clim.2014.10.006","article-title":"A\u00a0novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome","volume":"155","author":"Nabhani","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature01063","article-title":"Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency","volume":"419","author":"Chun","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2023.04.018_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.2011.01617.x","article-title":"Advances in autoimmune lymphoproliferative syndromes","volume":"87","author":"Madkaikar","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaip.2023.04.018_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","article-title":"Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II","volume":"98","author":"Wang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2023.04.018_bib69","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ajhg.2010.10.028","article-title":"Whole-exome-sequencing-based discovery of human FADD deficiency","volume":"87","author":"Bolze","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2013.02.019","article-title":"Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation","volume":"147","author":"Hauck","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib71","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/MPH.0000000000000785","article-title":"Use of sirolimus (rapamycin) for treatment of cytopenias and lymphoproliferation linked to autoimmune lymphoproliferative syndrome (ALPS). Two case reports","volume":"39","author":"Cayrol","year":"2017","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaip.2023.04.018_bib72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2016.07.017","article-title":"Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase \u03b4 syndrome","volume":"171","author":"Rae","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671755","article-title":"Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome-like phenotype: immunologic evaluation, early diagnosis and management","volume":"12","author":"L\u00f3pez-Nevado","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib75","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/blood-2010-07-295501","article-title":"Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis","volume":"117","author":"Niemela","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib76","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.2020005844","article-title":"Germline TET2 loss of function causes childhood immunodeficiency and lymphoma","volume":"136","author":"Stremenova Spegarova","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib77","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10875-008-9171-x","article-title":"Autoimmunity in hyper-IgM syndrome","volume":"28","author":"Jesus","year":"2008","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib78","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20180668","article-title":"Loss of human ICOSL results in combined immunodeficiency","volume":"215","author":"Roussel","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib79","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41591-021-01388-5","article-title":"Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child","volume":"27","author":"Ogishi","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib80","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib81","first-page":"436","article-title":"Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science (1979)"},{"key":"10.1016\/j.jaip.2023.04.018_bib82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","article-title":"Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation","volume":"19","author":"Salomon","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2015.07.008","article-title":"Novel monogenic diseases causing human autoimmunity","volume":"37","author":"Melki","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib84","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses","volume":"11","author":"Walker","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib85","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","article-title":"CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib86","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1038\/s41467-019-10812-x","article-title":"Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis","volume":"10","author":"Serwas","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2023.04.018_bib87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2015.04.007","article-title":"Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation","volume":"159","author":"Revel-Vilk","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib88","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jaip.2019.04.011","article-title":"Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review","volume":"7","author":"Habibi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.04.018_bib89","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2015.08.036","article-title":"Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4","volume":"137","author":"Lee","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib91","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib92","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","article-title":"Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score","volume":"145","author":"Tesch","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680334","article-title":"One gene, many facets: multiple immune pathway dysregulation in SOCS1 haploinsufficiency","volume":"12","author":"K\u00f6rholz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib94","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaip.2023.04.018_bib96","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","article-title":"JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome","volume":"139","author":"Del Bel","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib97","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","article-title":"Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea","volume":"129","author":"Ma","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib98","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib99","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2005.01.018","article-title":"Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry","volume":"22","author":"Yu","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2023.04.018_bib101","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib102","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jamadermatol.2014.5641","article-title":"Distinct cutaneous manifestations and cold-induced leukocyte activation associated with PLCG2 mutations","volume":"151","author":"Aderibigbe","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2023.04.018_bib103","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri.2016.93","article-title":"PI3K\u03b4 and primary immunodeficiencies","volume":"16","author":"Lucas","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib104","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0092-8674(91)90410-Z","article-title":"Cloning of PI3 kinase-associated p85 utilizing a novel method for expression\/cloning of target proteins for receptor tyrosine kinases","volume":"65","author":"Skolnik","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2023.04.018_bib107","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2016.03.059","article-title":"Immune dysregulation in patients with PTEN hamartoma tumor syndrome: analysis of FOXP3 regulatory T cells","volume":"139","author":"Chen","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib108","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u2018activated PI3K\u03b4 syndrome\u2019-targeted therapy with the PI3K\u03b4 inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib109","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajh.26452","article-title":"TLR8\/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins","volume":"97","author":"Fejtkova","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2023.04.018_bib110","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib111","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00109-016-1467-3","article-title":"Nucleic acid-mediated autoinflammation and autoimmunity\u2014type I interferonopathies","volume":"94","author":"Lee-Kirsch","year":"2016","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib112","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-018-0749-x","article-title":"An update on autoinflammatory diseases: relopathies","volume":"20","author":"Steiner","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaip.2023.04.018_bib113","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1111\/apa.16013","article-title":"Genetics and pathophysiology of haemophagocytic lymphohistiocytosis","volume":"110","author":"Meeths","year":"2021","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaip.2023.04.018_bib114","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s10875-014-0083-7","article-title":"XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP","volume":"34","author":"Tangye","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib116","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2023.04.018_bib117","series-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.jaip.2023.04.018_bib118","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/rheumatology\/kep387","article-title":"SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience","volume":"49","author":"Mehta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2023.04.018_bib119","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/08916930701510673","article-title":"Complement deficiencies and systemic lupus erythematosus","volume":"40","author":"Truedsson","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaip.2023.04.018_bib120","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature01315","article-title":"Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype","volume":"421","author":"Kemper","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2023.04.018_bib121","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1546-0096-10-21","article-title":"Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis","volume":"10","author":"Belot","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaip.2023.04.018_bib122","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11926-016-0621-9","article-title":"Monogenic lupus","volume":"18","author":"Lo","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaip.2023.04.018_bib123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaci.2013.07.035","article-title":"Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation","volume":"133","author":"Arkwright","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib124","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41525-019-0088-5","article-title":"Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease","volume":"4","author":"Keskitalo","year":"2019","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib125","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4161\/auto.28638","article-title":"Deficient autophagy unravels the ROS paradox in chronic granulomatous disease","volume":"10","author":"van de Veerdonk","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.jaip.2023.04.018_bib126","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaci.2017.04.035","article-title":"X-linked carriers of chronic granulomatous disease: illness, lyonization, and stability","volume":"141","author":"Marciano","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib127","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.833636","article-title":"High interferon signature leads to increased STAT1\/3\/5 phosphorylation in PBMCs from SLE patients by single cell mass cytometry","volume":"13","author":"Yiu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","article-title":"Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey","volume":"36","author":"Briggs","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMe1407246","article-title":"STING-associated vasculopathy with onset in infancy\u2014a new interferonopathy","volume":"371","author":"Crow","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12115","article-title":"Therapies in Aicardi-Gouti\u00e8res syndrome","volume":"175","author":"Crow","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib132","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib133","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513443","article-title":"Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Gouti\u00e8res syndrome","volume":"80","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib134","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.4103\/2229-5178.144522","article-title":"Chilblain lupus erythematosus in an adolescent girl","volume":"5","author":"Bansal","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaip.2023.04.018_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf9564","article-title":"Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency","volume":"6","author":"Magg","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib136","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI129301","article-title":"Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases","volume":"130","author":"de Jesus","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.04.018_bib137","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2023.04.018_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.935321","article-title":"Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders","volume":"13","author":"Bleesing","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib139","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrrheum.2014.170","article-title":"Autoinflammation: NLRC4 mutation causes rare autoinflammatory disease","volume":"10","author":"Bernard","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2023.04.018_bib140","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib141","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2023.04.018_bib142","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment strategies for deficiency of adenosine deaminase 2","volume":"380","author":"Ombrello","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib143","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients","volume":"41","author":"Hashem","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib144","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2019.00297","article-title":"Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2","volume":"10","author":"Klemann","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib146","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaci.2019.11.051","article-title":"Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations","volume":"146","author":"Lorenzini","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib147","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaci.2004.06.052","article-title":"Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia","volume":"114","author":"Orange","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib148","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1128\/MCB.01101-07","article-title":"IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway","volume":"27","author":"Hutti","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaip.2023.04.018_bib149","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/annrheumdis-2016-210944","article-title":"Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20)","volume":"77","author":"Duncan","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2023.04.018_bib150","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jaci.2016.09.038","article-title":"Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome","volume":"139","author":"Takagi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib151","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","article-title":"A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease","volume":"77","author":"Aeschlimann","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2023.04.018_bib152","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib153","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1038\/cti.2017.38","article-title":"Autoimmunity\/inflammation in a monogenic primary immunodeficiency cohort","volume":"6","author":"Rae","year":"2017","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib154","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood.V99.8.2694","article-title":"Autoimmunity in human primary immunodeficiency diseases","volume":"99","author":"Arkwright","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib156","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2018.00636","article-title":"Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond","volume":"9","author":"de Valles-Ib\u00e1\u00f1ez","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib157","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1073\/pnas.89.22.10653","article-title":"Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency","volume":"89","author":"Olerup","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaip.2023.04.018_bib158","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jaci.2016.07.011","article-title":"Killer cell immunoglobulin-like receptors are associated with common variable immune deficiency (CVID) pathogenesis","volume":"138","author":"Wang","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib159","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaci.2011.02.039","article-title":"Genome-wide association identifies diverse causes of common variable immunodeficiency","volume":"127","author":"Orange","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib161","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","article-title":"Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)","volume":"25","author":"Wang","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2023.04.018_bib162","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaip.2015.07.004","article-title":"Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings","volume":"3","author":"Maglione","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.04.018_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1081-1206(10)60853-8","article-title":"Pulmonary complications of common variable immunodeficiency","volume":"98","author":"Busse","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib164","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib165","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2016.07.040","article-title":"A\u00a0prospective study on the natural history of patients with profound combined immunodeficiency: an interim analysis","volume":"139","author":"Speckmann","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib166","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2007.02.001","article-title":"Impaired in\u00a0vitro regulatory T cell function associated with Wiskott-Aldrich syndrome","volume":"124","author":"Adriani","year":"2007","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib167","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.04.018_bib168","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.20150888","article-title":"A\u00a0novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70","volume":"213","author":"Chan","year":"2016","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib169","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa0900082","article-title":"STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity","volume":"360","author":"Picard","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib170","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.20151110","article-title":"Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT","volume":"213","author":"Keller","year":"2016","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib171","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2014-03-559542","article-title":"Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia","volume":"124","author":"Kiel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib172","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10875-020-00883-7","article-title":"Clinical spectrum of Ras-associated autoimmune leukoproliferative disorder (RALD)","volume":"41","author":"Neven","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib173","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3389\/fimmu.2017.01410","article-title":"Late-onset cryopyrin-associated periodic syndromes caused by somatic NLRP3 mosaicism\u2014UK single center experience","volume":"8","author":"Rowczenio","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib174","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2010-01-263145","article-title":"Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome","volume":"115","author":"Dowdell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.04.018_bib175","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib176","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2014.07.023","article-title":"The diagnostic approach to monogenic very early onset inflammatory bowel disease","volume":"147","author":"Uhlig","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.04.018_bib177","doi-asserted-by":"crossref","first-page":"12296","DOI":"10.3748\/wjg.v21.i43.12296","article-title":"Genetics of inflammatory bowel disease from multifactorial to monogenic forms","volume":"21","author":"Bianco","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.04.018_bib178","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1016\/j.cgh.2021.03.021","article-title":"A\u00a0systematic review of monogenic inflammatory bowel disease","volume":"20","author":"Nambu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.04.018_bib179","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ecco-jcc\/jjaa164","article-title":"Corrigendum to: diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicenter study","volume":"15","author":"Charbit-Henrion","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.jaip.2023.04.018_bib180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2016.05.042","article-title":"Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders [published correction appears in J Allergy Clin Immunol 2018;141:832","volume":"139","author":"Stray-Pedersen","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib181","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2016.05.035","article-title":"Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing","volume":"138","author":"Yu","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib182","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00125-018-4551-0","article-title":"A\u00a0type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes","volume":"61","author":"Johnson","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaip.2023.04.018_bib183","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12969-022-00700-y","article-title":"Monogenic disorders as mimics of juvenile idiopathic arthritis","volume":"20","author":"Furness","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaip.2023.04.018_bib184","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","article-title":"Copa syndrome: a novel autosomal dominant immune dysregulatory disease","volume":"36","author":"Vece","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib185","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201006","article-title":"LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages","volume":"218","author":"Omarjee","year":"2021","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib186","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2023.04.018_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215581","article-title":"Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-\u03b3 autoantibodies","volume":"14","author":"Angkasekwinai","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.04.018_bib188","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10875-014-0073-9","article-title":"The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-\u03b3 autoantibodies","volume":"34","author":"O\u2019Connell","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib189","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.180.1.647","article-title":"Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6","volume":"180","author":"Puel","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib190","article-title":"Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections","volume":"231","author":"Hetem\u00e4ki","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib191","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001709","article-title":"Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease","volume":"20","author":"Busnadiego","year":"2022","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jaip.2023.04.018_bib192","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s40618-020-01323-4","article-title":"A\u00a0COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor","volume":"43","author":"Beccuti","year":"2020","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jaip.2023.04.018_bib193","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science (1979)"},{"key":"10.1016\/j.jaip.2023.04.018_bib194","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib195","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00134-021-06392-4","article-title":"Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients","volume":"47","author":"Koning","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib196","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/imcb.12495","article-title":"Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19","volume":"99","author":"Abers","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaip.2023.04.018_bib197","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2023.04.018_bib198","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10875-021-01136-x","article-title":"Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in Barcelona","volume":"41","author":"Solanich","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib199","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151788","article-title":"Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19","volume":"131","author":"Arnold Egloff","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.04.018_bib200","doi-asserted-by":"crossref","first-page":"e1327","DOI":"10.1002\/cti2.1327","article-title":"Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients","volume":"10","author":"Goncalves","year":"2021","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib201","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/ng.3675","article-title":"Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency","volume":"48","author":"Bronson","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.04.018_bib202","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/1744666X.2016.1198696","article-title":"Monogenic mutations associated with IgA deficiency","volume":"12","author":"Abolhassani","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2023.04.018_bib203","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI115797","article-title":"Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency","volume":"89","author":"Volanakis","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.04.018_bib204","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1172\/JCI136254","article-title":"Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia","volume":"130","author":"Perez-Diez","year":"2020","journal-title":"J\u00a0Clin Invest"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823004580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823004580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:46Z","timestamp":1761975526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823004580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":204,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2213219823004580"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.04.018","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inborn Errors of Immunity and Autoimmune Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}